ADAPT PHARMA
ADAPT Pharma, a pharmaceutical company, develops and commercializes therapeutic treatments for patients with special medical conditions. The company offers NARCAN (naloxone hydrochloride) Nasal Spray, an opioid antagonist indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression.
ADAPT PHARMA
Industry:
Pharmaceutical
Founded:
2014-01-01
Address:
Radnor, Pennsylvania, United States
Country:
United States
Website Url:
http://www.adaptpharma.com
Total Employee:
11+
Status:
Closed
Contact:
+1-844-232-7811
Email Addresses:
[email protected]
Technology used in webpage:
SPF Amazon IPv6 Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy DNS Microsoft AWS Global Accelerator Cisco Ironport Cloud
Similar Organizations
AskGene Pharma
AskGene Pharma is a pharmaceuticals company.
Fosun Pharma
Fosun Pharma is a pharmaceutical company.
KBP Biosciences
A multinational clinical stage biotechnology company.
Nymox Pharmaceutical
Nymox Pharmaceutical is a biopharmaceutical company.
Current Employees Featured
Founder
Official Site Inspections
http://www.adaptpharma.com
- Host name: edge.redirect.pizza
- IP address: 89.106.200.1
- Location: Luxembourg
- Latitude: 49.7498
- Longitude: 6.1661
- Timezone: Europe/Luxembourg
More informations about "Adapt Pharma"
Adapt Pharma - Crunchbase Company Profile & Funding
ADAPT Pharma, a pharmaceutical company, develops and commercializes therapeutic treatments for patients with special medical conditions. The company offers NARCAN (naloxone hydrochloride) Nasal Spray, an opioid antagonist …See details»
Emergent BioSolutions Completes Acquisition of Adapt Pharma …
Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has completed its acquisition of Adapt Pharma and its flagship product NARCAN® (naloxone HCl) Nasal Spray, the first and …See details»
Adapt Pharma Company Profile 2024: Valuation, Investors
Adapt Pharma General Information Description. Developer of therapeutic treatments for medical patients. The company's operation include providing cutting-edge new treatment options in the …See details»
Adapt Pharma Information - RocketReach
Adapt Pharma is an innovative small business focused on developing cutting-edge treatments for patients with special medical conditions. Our mission is to provide simple, reliable, and …See details»
Emergent BioSolutions Joins Effort to Combat National Public …
Aug 28, 2018 Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into an agreement to acquire Adapt Pharma and its flagship product NARCAN® (naloxone HCl) …See details»
Emergent BioSolutions to acquire Adapt Pharma for up to $735m
Emergent BioSolutions CEO Daniel Abdun-Nabi said: “Adding this important life-saving product to our portfolio of preparedness solutions allows us to apply our experience gained from two …See details»
Adapt Pharma - Overview, News & Similar companies - ZoomInfo
Nov 20, 2021 Who is Adapt Pharma. Adapt Pharma Limited is a privately held pharmaceutical company committed to positively impacting the lives of patients with specialist medical con …See details»
ADAPT Pharma® to be Acquired by Emergent BioSolutions
Sep 4, 2018 ADAPT Pharma today announced that it has entered into a definitive agreement to be acquired by Emergent BioSolutions. Adapt is solely focused on helping address the opioid …See details»
Adapt Pharma - Contacts, Employees, Board Members
ADAPT Pharma, a pharmaceutical company. Unlock even more features with Crunchbase ProSee details»
Emergent BioSolutions Acquires Adapt Pharma in $735 Million Deal
Aug 29, 2018 Touting that it is helping fight the opioid epidemic, Emergent BioSolutions is acquiring Adapt Pharma. Under the terms of the deal, Emergent will pay $635 million up front …See details»
OPNT: Adapt Pharma® Acquired for $650 Million… - Yahoo Finance
On August 28, 2018, Emergent Biosciences Inc. announced the acquisition of Adapt Pharma® for $635 million with the potential for another $100 million in sales-based milestones through 2022.See details»
Emergent BioSolutions to buy Adapt Pharma for up to $735 mln
Aug 28, 2018 Emergent BioSolutions Inc said on Tuesday it would buy privately held Adapt Pharma for up to $735 million to acquire its drug Narcan, the only needle-free emergency …See details»
Adapt Pharma® Welcomes Canadian & Ontario Governments
Apr 9, 2018 For more information, please visit www.adaptpharma.com. I Cotter, John. ... Organization Profile. Adapt Pharma. Contact Cision. 866-245-2317 from 8 AM - 10 PM ET …See details»
Eyeing $1B in annual sales, Emergent BioSolutions to buy Narcan …
Aug 29, 2018 Emergent BioSolutions is mobilizing its M&A war chest again. Hard on the heels of its $270 million deal for vaccine expert PaxVax, the frequent government contractor is buying …See details»
Adapt Pharma Canada Ltd. / Adapt Pharma Canada Ltd. / Evan …
Individual, organization or corporation with a Direct Interest Beneficiary Information The activities of Adapt Pharma Canada Ltd. / Adapt Pharma Canada Ltd. are not controlled or directed by …See details»
Emergent BioSolutions – Global Specialty Life Sciences Company
Emergent BioSolutions Appoints Dr. Simon Lowry as Chief Medical Officer and Head of Research and Development GAITHERSBURG, Md., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Emergent …See details»
Adapt Pharma Expands Technical and R&D Teams - Newswire
Mar 5, 2018 For more information, please visit www.adaptpharma.com. SOURCE Adapt Pharma Thom Duddy, Executive Director - Communications, Adapt Pharma®, [email protected] , 484 …See details»
FOR IMMEDIATE RELEASE Investor Contact: Media Contacts
[email protected] EMERGENT BIOSOLUTIONS COMPLETES ACQUISITION OF ADAPT PHARMA AND FLAGSHIP PRODUCT NARCAN® (naloxone HCl) NASAL SPRAY …See details»
After $500 Million Exit, Pharma Experts Shift Focus To This …
Jul 21, 2016 NEW YORK, NY / ACCESSWIRE / July 21, 2016 / Seamus Mulligan, Eunan Maguire and David Brabazon formed Adapt Pharma in 2014, after a $500 Million exit with Azur …See details»
Adapt Pharma Limited | Insights
Feb 16, 2023 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»